CVE-2015-10038: A vulnerability was found in nym3r0s pplv2
CVE-2015-10038 is a medium-severity flaw (CVSS 5.5) affecting pplv2. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
A vulnerability was found in nym3r0s pplv2. It has been declared as critical. Affected by this vulnerability is an unknown functionality. The manipulation leads to sql injection. The patch is named 28f8b0550104044da09f04659797487c59f85b00. It is recommended to apply a patch to fix this issue. The associated identifier of this vulnerability is VDB-218023.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 5.5 (Medium) |
| Attack vector | Adjacent network |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | None |
| EPSS exploit chance | 0.8% (top 42%) |
| CISA exploited list | No |
| Weakness | CWE-89 |
| Published | 2023-01-11 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2015-10038?
pplv2: mitigate or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2015-10038 being exploited?
CVE-2015-10038 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2015-10038 affect?
CVE-2015-10038 affects pplv2. Severity is medium (CVSS 5.5). A vulnerability was found in nym3r0s pplv2. It has been declared as critical. Affected by this vulnerability is an unknown functionality. The manipulation leads to sql injection. The patch is named 28f8b0550104044da09f04659797487c59f85b00.
How urgent is CVE-2015-10038?
Priority 34/100. No elevated risk signals yet.